BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3576523)

  • 1. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of urinary fibrin/fibrinogen degradation products by radioimmunoassay.
    Ekberg M; Hedner U; Larsson I; Nilsson IM; Nosslin B
    Scand J Clin Lab Invest; 1976 Sep; 36(5):453-9. PubMed ID: 790536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of urinary excretion of fibrin degradation products during treatment of glomerulonephritis.
    Michielsen P; Roels L; Vanrenterghem Y; Boel A; van Damme B; Vermylen J
    Clin Nephrol; 1976 Mar; 5(3):105-13. PubMed ID: 1261101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fibrin and fibrinogen degradation products (FDP) in renal diseases. II. Serum and urinary FDP in different morphological forms of glomerulonephritis].
    Ratajczak T; Rabczyński J; Szewczyk Z
    Pol Arch Med Wewn; 1978 Apr; 59(4):429-40. PubMed ID: 662758
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urinary cross-linked FDP in various renal diseases].
    Inuma H
    Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary fibrin/fibrinogen degradation products (FDP) in chronic glomerulonephritis].
    Shimamatsu K
    Fukuoka Igaku Zasshi; 1986 Sep; 77(9):480-9. PubMed ID: 3804170
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical significance of urinary fibrin/fibrinogen degradation products (FDP) as measured by latex photometric immunoassay in renal diseases.
    Kaizu K; Ito Y; Uriu K; Eto S
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):29-34. PubMed ID: 8336397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of fibrinolytic degradation products in concentrated urine after renal transplantation.
    Ekberg M; Bergentz SE; Hedner U; Nilsson IM
    Scand J Urol Nephrol; 1976; 10(1):56-62. PubMed ID: 775625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrin and fibrinogen degradation products in renal diseases. I. FDP in blood and urine in various stages of clinical glomerulonephritis].
    Ratajczak T; Szewczyk Z; Melcer H
    Pol Arch Med Wewn; 1977 Nov; 58(5):481-92. PubMed ID: 600826
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of urinary and circulating FDP subfragments and subunits: application of the western-blot technique.
    Takahashi S; Noguchi Y; Kitagawa T
    Acta Paediatr Jpn; 1989 Apr; 31(2):127-35. PubMed ID: 2516692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of urinary fibrin/fibrinogen degradation product (FDP) D-dimer measured by highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases].
    Shibata T; Magari Y; Mizunaga S; Okabe E; Sumie A; Ishii T; Tomo T; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):805-12. PubMed ID: 8072218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
    Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
    Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of urinary FDP-E measured by latex photometric immunoassay (LPIA) in the renal disease].
    Kaizu K; Ito Y; Uriu K; Komine N; Hashimoto O; Eto S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):365-71. PubMed ID: 1875556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of physical exercise on blood and urinary FDP levels in chronic glomerulonephritis].
    Trznadel K; Lewicki R
    Pol Arch Med Wewn; 1978 Sep; 60(3):269-75. PubMed ID: 714721
    [No Abstract]   [Full Text] [Related]  

  • 18. Urinary fibrin degradation products--a three year comparative study.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases.
    Tishkov I; Tschoukanov C; Doytshinov D; Shipkova P
    Int Urol Nephrol; 1982; 14(1):89-93. PubMed ID: 7118491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of urinary fibrin degradation products.
    Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H
    Nephron; 1980; 25(1):25-9. PubMed ID: 6986037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.